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Introduction: Preimplantation genetic diagnosis and/or screening (PGD/PGS) allow the assessment of the genetic
health of an embryo before transferring it into the uterus. These techniques require the removal of cellular material
(polar bodies, blastomere(s) or trophectoderm cells) in order to perform the proper genetic analysis. We report the
implantation and live birth outcome of a vitrified-warmed blastocyst developed after triple biopsy and double
vitrification procedures at oocyte, cleavage embryo and blastocyst stage.
Case description: An infertile couple, with family history of β-thalassemia, searched for IVF procedure and PGD.
First polar bodies biopsy with subsequent vitrification was uninformative due to meiotic crossing-over, so oocytes
were inseminated after warming. Two embryos were obtained and blastomere biopsy was performed on day 3 with
inconclusive results on their genetic status. Their culture resulted in one expanded blastocyst stage on day 7 that
underwent trophectoderm biopsy and vitrification. This embryo showed to be normal. It was then warmed and
transferred in an artificial cycle.
Discussion and Evaluation: Preconception genetic analysis by removal and analysis of the first polar body is
technically possible, but the genetic information that we can obtain at this stage may be limited and the oocytes
to be inseminated is not predictable. Compared to blastomere biopsy, trophectoderm biopsy has more diagnostic
efficiency with respect to both chromosomal mosaicism and PCR accuracy, reducing the problems of amplification
failure and allele drop out. Moreover, embryos biopsied at the cleavage stage seem to have lower implantation rate
than biopsied blastocyst.
Conclusions: This is the first case report of a live birth obtained from a three step biopsy and double vitrification
procedures of a blastocyst. This case report seems also to suggest the harmlessness of all these procedures if
carefully performed by a skilled biologist in an IVF lab with quality management system. Finally, our study highlight
that blastocyst cryopreserved on day 7 have clinically important potential and embryos that not reach blastocyst
stage on day 6 should not to be discharged because they may result in an ongoing pregnancy.
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Preimplantation genetic diagnosis and/or screening (PGD/
PGS) allow the assessment of the genetic health of an em-
bryo before transferring it into the uterus. These tech-
niques require the removal of cellular material in order to
perform the proper genetic analysis.
Potential sources of genetic material are: first (1 PB)
and second polar bodies (2 PB), day 3 embryo blasto-
meres, and blastocyst trophectoderm cells (Brezina et al.
2013; Greco et al. 2013). All these techniques require
several laboratory manipulation procedures before em-
bryo transfer: oocyte zona pellucida laser drilling, em-
bryo biopsy, cryopreservation and thawing, that might
affect embryo survival and its implantation potential
(Scott et al. 2013a; Zhang et al. 2009).
One of the most critical point in PGD/PGS programs
is assessing the right time to do the genetic analysis. In
fact this issue needs careful considerations: accurate
identification of the genetic status of the oocyte in case
of monogenic disease especially when only the first polar
body is analyzed, the possibility of mosaicism phenome-
non and self correction mechanism at cleavage stage em-
bryo, minimization of the biopsy adverse effect on the
embryo (Scott et al. 2013a).
We report a normal blastocyst development and a suc-
cessful live birth after sequential application of multiple
potentially invasive biological micromanipulation tech-
niques (polar body, blastomere and trophectoderm biopsy)
and repeated vitrification and warming procedures.
Case presentation
An infertile couple, with family history of β-thalassemia
(Galanello and Origa 2010) searched for IVF procedure
and preimplantation genetic diagnosis (PGD): a 37 year
old woman and a 38 year old man, carriers of the IVS1-
110 G > A and the Cod 39C > T mutations in the HBB
gene (OMIM 141900), respectively. Seminal fluid exam-
ination according to the WHO recommendation (WHO
2010) showed a severe oligoastenoteratozoospermia.
Ovarian reserve was evaluated combining antral follicle
count (AFC), day 3 FSH and Antimullerian (AMH) dosage
(Fleming et al. 2013). A written consent of the couple was
obtained.
This study was approved by the Institutional Ethical
Committee of the European Hospital and Genoma group.
All techniques were performed according to the Helsinki
declaration of 1975 and its modifications.
Controlled ovarian stimulation was performed using a
long gonadotrophin-releasing hormone (GnRH) agonist
suppression protocol starting on the 21st day of the pre-
ceding cycle until the day of triggering; recombinant FSH
administration (GonalF, MerkSerono, Italy) was started on
the 3rd day of the cycle. When at least 3 follicles reached
19 mm in diameter, 10.000 UI hCG (Gonasi, 10.000 UI,IBSA, Lodi, Italy) was administered by intramuscular
injection (Huber et al. 2013). Thirty-six hour later, ten
oocytes were retrieved through an ultrasound-guided
transvaginal follicular puncture; five of them were
found to be metaphase II.
Polar body analysis was chosen as the first diagnostic
option for ethical reasons. Polar body biopsy consisted in
opening the zona pellucida using infrared laser drilling.
Using a polar body biopsy pipette, polar bodies were ex-
tracted from oocytes (Humagen, Origio, Charlostesville,
VA, USA) through an hole into the perivitelline space
making a gentle suction. After the biopsy oocytes were vit-
rified (Montag et al. 2013).
For cleavage stage, the blastomere biopsy pipette
(Humagen, Origio, Charlostesville, VA, USA) was intro-
duced inside the embryo using the same hole. After biopsy
embryos were transferred to sequential culture media
(Quinn’s Advantage Blastocyst medium, SAGE, Cooper-
Surgical, Pasadena, CA, USA) (Kaser and Ginsburg 2014).
For blastocyst stage, using a combination of gently
suction with blastomere aspiration pipette (COOK,
Ireland) and the proper number of laser pulses (each
one of 3,7 intensity) (Chang et al. 2013), around 6-8
trophectoderm cells were dissected from the expanded
blastocyst. The blastocyst was then vitrified.
The biopsied cells were placed in RNase-DNase-free
0.2 ml PCR tubes using a 130 μm glass pipette (Humagen,
Origio, Charlostesville, VA, USA), in the same way for all
three kinds of cells biopsied and sent for genetic analysis.
PCR conditions used and the strategy used for mutation
analysis are described elsewhere (Fiorentino et al. 2006).
Vitrification, thawing procedure and materials were
the same for oocytes, embryos and blastocyst (Cryotop
and Vitrification kit, Kitazato Supply, Shizuoka, Japan)
(Mukaida and Oka 2012).
Five oocytes were submitted to PB biopsy and vitrifica-
tion. Their genetic analysis revealed that one of the oo-
cytes carried the mutation, three oocytes could not be
diagnosed due to their recombinant state and one oocyte
was excluded because was in telophase I stage and not
suitable for biopsy. After a genetic counselling, the couple
decided to proceed with the insemination of the three
recombinant oocytes. The vitrified oocytes were warmed
and the ICSI procedure was performed on the two
survived, obtaining two 72 h cleavage stage embryos sub-
mitted to one-blastomere biopsy. Genetic analysis was un-
informative, so a new biopsy was performed on the
trophectoderm cells of an expanded blastocyst on day 7
immediately vitrified (Figure 1). The PCR analysis revealed
that the embryo was healthy carrier for β-thalassemia and
suitable for transfer.
The blastocyst was warmed and transferred on the
scheduled day (Figure 2). Frozen-thawed blastocyst trans-
fer was perfomed in an artificial cycle combining
Figure 1 Polar body (A), blastomere (B) and trophectoderm (C) biopsies.
Greco et al. SpringerPlus  (2015) 4:22 Page 3 of 5gonadotrophin-releasing hormone agonist and estrogen
pill (Progynova, Bayer, New Zealand limited, Auckland).
Transfer was carried under ultrasound guidance when
endometrium thickness reached 8 mm. Intramuscular ad-
ministration of progesterone in oil (Prontogest, IBSA,
Lodi, Italy) was initiated 5 days before embryo transfer
(Hill et al. 2010).
A positive β-HCG was obtained 11 days after embryo
transfer and fetal heart beat was confirmed by ultra-
sound observation 7 weeks after. The patient delivered
an healthy boy weighting 3.900 g at 40 weeks of gesta-
tion. No neonatal problems have been reported.
Discussion
This is the first case report of a live birth obtained from
a three step biopsy and double vitrification procedures
of a blastocyst. Many biological and clinical consider-
ations can be drawn from this case. Preconception gen-
etic analysis by removal and analysis of the first polar
body is technically possible, but the genetic information
that we can obtain at this stage may be limited and the
oocytes to be inseminated is not predictable. Theoretic-
ally, the biopsy and genetic analysis of the first polar
body is likely to have some advantages respect to preim-
plantation diagnosis performed on the blastomere or
trophectoderm cells. Biopsy of the oocyte prior to
fertilization is ethically accepted since it does not requireFigure 2 Day-7 biopsied blastocyst wich resulted in a healthy boy, im
before the transfer (B).manipulation of the pre-embryo. Our study confirms
that aspiration of the first polar body seems to have no
detrimental effects on fertilization or quality of the em-
bryonic development until to the blastocyst stage be-
cause it is not involved in all these processes (Macas
et al. 2011). Different studies, on the contrary, showed
that day 3 embryos that undergone blastomere biopsy
had more fragmentation and showed a slower cell div-
ision if compared with unbiopsied controls, but no de-
finitive conclusion on the safety of PB biopsy with
respect to the embryo implantation potential is available
at present because all the published studies are under-
powered (Montag et al. 2013; Levin et al. 2012). Bio-
logical availability of oocytes for first polar body biopsy
can also be reduced at methaphase II stage. In fact, re-
cent investigations have demonstrated that some oocytes
showing a first PB may still be in telophase I stage due
to the presence of a connective spindle strand between
the first PB and the oocyte, as occurred in the present
case (Montag et al. 2006). Often vitrification of the biop-
sied oocytes is necessary if the genetic analysis needs
time because their fertilization rate decrease if too much
time intercourses between the oocytes denudation and
intracytoplasmic sperm injection (Patrat et al. 2012).
Preconception diagnosis by the removal and PCR ana-
lysis of the first polar body has been successfully applied
to many genetic diseases, including sickle cell anaemiamediately after the warming (A) and two hours after incubation
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Chehab et al. 1987), β-thalassaemia (Saiki et al. 1988),
cystic fibrosis (Kerem et al. 1989), Duchenne's muscu-
lar dystrophy (Speer et al. 1989) and Tay Sach's disease
(Myerowitz 1988; Myerowitz and Costigan 1988) but the
possibility of crossing over between homologous chromo-
somes must be considered. If this occurs, the primary oo-
cytes will be heterozygous for the abnormal gene and the
genotype of the oocyte is not correctly predictable. The
probability of a crossing over occurring between any gene
and the centromere is a function of the distance of the
gene from the centromere. For telomeric genes, crossing
over occurs with sufficient frequency that the genes segre-
gate independently from the centromere. For telomeric
genes the prediction is that one quarter of aspirated polar
bodies will give the correct information and consequently
only one quarter of the oocytes will be suitable for the
ICSI procedure. For genes situated close to the telomere,
the percentage of meiosis with crossing over between the
locus and the centromere will be lower (Verlinsky et al.
1990). Our results are agree with others studies in which
the percentage of recombinant oocytes for beta thalas-
semia gene was very high (Verlinsky et al. 1997; Fiorentino
et al. 2008). In these cases biopsy of both polar bodies or
biopsy of blastomere at cleavage stage, if the analysis of
paternally derived mutations is needed, is necessary to
give complete genetic information (Kuliev and Rechitsky
2011).
Allele drop out (ADO) and amplification failure of
both alleles are well known phenomena in PCR on single
cells. This can depend on several reasons: the cell type
employed for the PCR (Rechitsky et al. 1998), genes and
markers (Dreesen et al. 1996), lysis and PCR conditions
(Levinson et al. 1992; Gitlin et al. 1996; Ray et al. 1996).
Trophectoderm biopsy has more diagnostic efficiency
with respect to both chromosomal mosaicism and PCR
accuracy, reducing the problems of amplification failure
and allele drop out (Chang et al. 2013; Yang et al. 2013).
Moreover we have to consider the effect of biopsy on
implantation at cleavage stage embryos. A recent ran-
domized controlled trial demonstrated that embryos bi-
opsied at the cleavage stage have lower implantation rate
than biopsied blastocyst (Goossens et al. 2008; Scott
et al. 2013b).
In a recent publication is demonstrated that blastocyst
cryopreserved on day 7 have lower but clinically import-
ant potential, as in our study (Kovalevsky et al. 2013).
For this reason, embryos that not reach blastocyst stage
on day 6 should not to be discharged because they may
result in an ongoing pregnancy.
Cryopreservation of oocytes, embryos and blastocysts
is currently used technique in reproductive medicine
(Chhabra and Kutchi 2013; Cobo et al. 2011; Bhattacharya
and Kamath 2013). Attempts of using conventional slow-freezing protocols in PGD programs have shown not to be
successful, since the lack of the intact zona pellucida pro-
tection causes crystal formation that implies extensive
damage after thawing. Vitrification protocols, reducing the
formation of intracellular ice crystals provides better pro-
tection from cryoinjury (AbdelHafez et al. 2010). Different
clinical studies have demonstrated both high survival rates
of frozen thawed oocytes, embryos and high implantation
rates and live births of euploid biopsied blastocysts (Borini
et al. 2008). Our study seems also to suggest the harmless-
ness of all these procedures if carefully performed by a
skilled biologist in an IVF lab with quality management
system (Practice Committees of ASRM 2013).
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